GlassScriptPhysician profile
Mary K Weeks
NPI 1689299406
$689.55
in general payments reported to CMS, 2019-2025
19 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $279 · 2022: $85.41 · 2023: $80.49 · 2024: $139 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $87.50 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $73.91 | 2021-2022 | |
| Astellas Pharma US INC | $68.89 | 2025 | Veozah |
| Exeltis, USA INC. | $65.69 | 2023-2024 | Slynd |
| Exact Sciences Corporation | $64.02 | 2023 | Cologuard Collection Kit |
| Organon LLC | $45.97 | 2024-2025 | Nexplanon |
| Amarin Pharma, INC. | $45.23 | 2021-2022 | |
| Novo Nordisk INC | $41.06 | 2022 | |
| Merck Sharp & Dohme LLC | $29.07 | 2021 | |
| Sumitomo Pharma America, INC. | $24.71 | 2025 | Myfembree |
| Edwards Lifesciences Corporation | $22.10 | 2021 | |
| Sage Therapeutics, LLC | $20.24 | 2024 | |
| Daiichi Sankyo INC. | $18.17 | 2024 | Injectafer |
| Agile Therapeutics, INC. | $17.41 | 2024 | Twirla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.83 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.10 | 2021 | |
| Abbvie INC. | $11.67 | 2022 | |
| Hikma Pharmaceuticals USA | $11.49 | 2021 | |
| Eyevance Pharmaceuticals LLC | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Weeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.